Veracyte
VCYT
246 hedge funds and large institutions have $1.82B invested in Veracyte in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 117 increasing their positions, 67 reducing their positions, and 37 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 67
2.77% more ownership
Funds ownership: 106.57% → 109.34% (+2.8%)
5% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 37
2% less funds holding
Funds holding: 250 → 246 (-4)
15% less capital invested
Capital invested by funds: $2.14B → $1.82B (-$324M)
47% less call options, than puts
Call options by funds: $976K | Put options by funds: $1.85M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$29.7M |
| 2 |
CC
Casdin Capital
New York
|
+$20.9M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$16.6M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$12.4M |
| 5 |
Renaissance Technologies
New York
|
+$10M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$16.6M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$15.8M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$15M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$11.2M |
| 5 |
Goldman Sachs
New York
|
-$5.83M |
VCYT Hedge Fund Activity: Q1 2024 in Review
246 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2024, worth a combined $1.82B — down 15% from $2.14B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of VCYT and 35 opened new positions — a net loss of 2 holders — while 67 trimmed existing stakes and 117 added.
The largest buyer was State Street, adding an estimated $29.7M. The largest seller was Morgan Stanley, cutting an estimated $16.6M.
- 246 institutional investors held Veracyte (VCYT) as of Q1 2024, down from 250 in Q4 2023.
- Funds reported $1.82B of Veracyte stock for Q1 2024, down 15% quarter-over-quarter.
- 35 funds opened new Veracyte positions in Q1 2024 and 37 closed out, a net change of -2 holders.
- The largest Veracyte buyer in Q1 2024 was State Street, an estimated $29.7M added.
- The largest Veracyte seller in Q1 2024 was Morgan Stanley, an estimated $16.6M sold.
Based on aggregated 13F filings for Q1 2024.